Innovation to Commercialization Pipeline (ICP) Program: Applications Oct 13 – Nov 14
OnlineThe Innovation to Commercialization Pipeline (ICP) program, co-led by Forward BIOLABS and BioForward, is designed to support emerging Wisconsin biohealth companies in navigating the complex journey from discovery to market. The ICP program aims to overcome critical commercialization barriers and capital-access gaps by providing emerging companies with targeted funding to obtain the tools, resources, and vital support they need to scale. Eligible companies can apply for tailored, company-specific support designed to accelerate their commercialization journey, empowering them to reduce scaling risks and attract future investment.